Login / Signup

Antibody responses and correlates after two and three doses of BNT162b2 COVID-19 vaccine.

Shohei YamamotoAkihito TanakaYusuke OshiroNatsumi InamuraTetsuya MizoueNorio Ohmagarinull null
Published in: Infection (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus